Pfizer says Pandemic could Extend to 2024
Pfizer Inc forecasted that the COVID-19 pandemic would not be behind us until at least 2024 and said a lower-dose version of its vaccine for 2- to 4-year-olds generated a weaker immune response than expected, potentially delaying authorization.
Pfizer’s Chief Scientific Officer said in a presentation to investors that the company expects some regions to continue to see pandemic levels of COVID-19 cases over the next year or two. Other countries will transition to “endemic” with low, manageable caseloads during that same time period.
You may also like
COVID Comeback – A new Threat for European Market Bulls
COVID-19 lockdowns have returned anew to haunt Europe’s economic prospects, forcing investors
Omicron could Deal another Blow to Supply Chains
Just as it appeared like the crisis was beginning to stabilize, the industry may now face yet anothe
BioNTech sees up to EUR 17 B in Vaccine Revenue
Germany’s BioNTech SE said the COVID-19 vaccine it is developing with Pfizer will likely gener
Post a comment